• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


1.123 EUR 0.020 1.81%

As of 13:02:08 ET on 01/23/2015.

Snapshot for Zogenix Inc (Z08)

Open: 1.103 Day's Range: 1.044 - 1.129 Volume: 13,000
Previous Close: 1.103 52wk Range: 0.827 - 34.230 1-Yr Rtn: -64.38%

Stock Chart for Z08

No chart data available.
  • Z08:GR 1.044
  • 1D
  • 1M
  • 1Y
Interactive Z08 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for Z08

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4900
Est. PEG Ratio -
Market Cap (M EUR) 171.86
Shares Outstanding (M) 153.04
30 Day Average Volume 1,456
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for Z08

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for Z08

Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.

Roger L HawleyCEO/Interim Chief Commercial OfcrStephen J FarrPresident/Co-Founder
Ann D RhoadsExec VP/CFO/Treasurer/SecyBradley Stuart Galer "Brad Gale"Exec VP/Chief Medical Officer
More Company Profile & Key Executives for Z08

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil